Pediatric Cardiology

, Volume 38, Issue 7, pp 1515–1518 | Cite as

Chronic Low Dose Prostaglandin and Neonatal Heart Block

  • Safwat A. Aly
  • Sawsan M. Awad
  • Ra-id Abdulla
  • Suhaib Kazmouz
  • Hoang H. Nguyen
Case Report

Abstract

Long-term prostaglandin use is commonly associated with side effects such as cortical proliferation of the bones, hypertrophic pyloric stenosis, and soft tissue swelling of the extremities. We report a neonate with critical coarctation of the aorta, who developed second and third degree atrioventricular blocks associated with prolonged prostaglandin E1 (PGE1) infusion. Interestingly, these conduction blocks only occurred at low PGE1 dose. The rhythm disturbances resolved promptly with the discontinuation of PGE1 following surgical repair.

Keywords

Heart Block Prostaglandin PGE1 

Notes

Compliance with Ethical Standards

Conflict of interest

All the authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Beamish RE, Das PK, Karmazyn M, Dhalla NS (1985) Prostaglandins and heart disease. Can J Cardiol 1:66–74PubMedGoogle Scholar
  2. 2.
    Bourke KD, Sondheimer HM, Ivy DD, Pietra B, Gleason BK, Mashburn C, Boucek MM (2003) Improved pretransplant management of infants with hypoplastic left heart syndrome enables discharge to home while waiting for transplantation. Pediatr Cardiol 24:538–543CrossRefPubMedGoogle Scholar
  3. 3.
    Aykanat A, Yavuz T, Ozalkaya E, Topcuoglu S, Ovali F, Karatekin G (2016) Long-term prostaglandin E1 infusion for newborns with critical congenital heart disease. Pediatr Cardiol 37:131–134CrossRefPubMedGoogle Scholar
  4. 4.
    Peled N, Dagan O, Babyn P, Silver MM, Barker G, Hellmann J, Scolnik D, Koren G (1992) Gastric-outlet obstruction induced by prostaglandin therapy in neonates. N Engl J Med 327:505–510CrossRefPubMedGoogle Scholar
  5. 5.
  6. 6.
    Alhussin W, Verklan MT (2016) Complications of long-term prostaglandin E1 use in newborns with ductal-dependent critical congenital heart disease. J Perinat Neonatal Nurs 30:73–79CrossRefPubMedGoogle Scholar
  7. 7.
    Ustun N, Dilli D, Zenciroglu A, Okumus N, Cinar G, Ozgur S, Koc M (2013) Long-term prostaglandin E1 use in newborns with duct-dependent congenital heart diseases: one year experience of a tertiary neonatal intensive care unit in Turkey. Anadolu Kardiyol Derg 13:732–734PubMedGoogle Scholar
  8. 8.
    Lewis AB, Freed MD, Heymann MA, Roehl SL, Kensey RC (1981) Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64:893–898CrossRefPubMedGoogle Scholar
  9. 9.
    De Smit E, Theodorou M, Hildebrand GD, Bloom P (2011) Heart block following topical latanoprost treatment. BMJ Case Rep. doi: 10.1136/bcr.08.2011.4607 PubMedPubMedCentralGoogle Scholar
  10. 10.
    Swift A, Karmazyn M, Horrobin DF, Manku MS, Karmali RA, Morgan RO, Ally AI (1978) Low prostaglandin concentrations cause cardiac rhythm disturbances. Effect reversed by low levels of copper or chloroquine. Prostaglandins 15:651–657CrossRefPubMedGoogle Scholar
  11. 11.
    Karmazyn M, Dhalla NS (1980) A selective concentration-dependent dysrhythmogenic and antidysrhythmic action of prostaglandins E2, F2 alpha and I2 (prostacyclin) on isolated rat hearts. Experientia 36:996–998CrossRefPubMedGoogle Scholar
  12. 12.
    Rao TS, Seth SD, Manchanda SC, Nayar U (1989) Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis. Arch Int Pharmacodyn Ther 302:128–144PubMedGoogle Scholar
  13. 13.
    Anderson RH, Becker AE, Arnold R, Wilkinson JL (1974) The conducting tissues in congenitally corrected transposition. Circulation 50:911–923CrossRefPubMedGoogle Scholar
  14. 14.
    Baruteau AE, Pass RH, Thambo JB, Behaghel A, Le Pennec S, Perdreau E, Combes N, Liberman L, McLeod CJ (2016) Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management. Eur J Pediatr 175:1235–1248CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Johansen AS, Herlin T (1998) Neonatal lupus syndrome. Association with complete congenital atrioventricular block. Ugeskr Laeger 160:2521–2525PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Safwat A. Aly
    • 1
  • Sawsan M. Awad
    • 1
  • Ra-id Abdulla
    • 1
  • Suhaib Kazmouz
    • 1
  • Hoang H. Nguyen
    • 1
  1. 1.Department of Pediatrics, Division of CardiologyRush University Medical CollegeChicagoUSA

Personalised recommendations